Therapeutic Goods Regulations (Amendment)

Overview

The Therapeutic Goods Regulations (Amendment) 1995 No. 328, issued under the authority of the Minister for Family Services, amends the Therapeutic Goods Regulations 1990 to reflect the changes introduced by the Competition Policy Reform Act 1995. The Therapeutic Goods Act 1989, established to ensure the quality, safety, efficacy, and timely availability of therapeutic goods within Australia and for export, empowers the Governor-General to enact regulations necessary for the Act's effective implementation. Specifically, Regulation 2 of the Therapeutic Goods Regulations, which references the "Therapeutic Goods Advertising Code" authorised by the Trade Practices Commission, is amended to update the reference to the Australian Competition and Consumer Commission, the entity that succeeded the Trade Practices Commission under the new legislative framework. This amendment ensures the continuity and applicability of the Advertising Code within the updated regulatory environment, facilitating the enforcement of advertising standards for therapeutic goods in alignment with contemporary competition and consumer protection policies.

Scope and Application

The Therapeutic Goods Act 1989 applies to all therapeutic goods used or exported from Australia, encompassing a broad range of products including medicines, medical devices, blood, and tissues. The Act seeks to ensure the quality, safety, efficacy, and timely availability of these goods through a national system of controls. It applies to entities such as manufacturers, importers, and suppliers of therapeutic goods, as well as to the conduct of advertising and selling these products. Geographically, the Act has a national reach, impacting all states and territories within Australia. The Act is enforced through subordinate instruments, including the Therapeutic Goods Regulations, which are amended as necessary to keep pace with changes in industry and regulatory frameworks. Notably, the Therapeutic Goods Regulations (Amendment) 1995, which updated the name from the Trade Practices Commission to the Australian Competition and Consumer Commission, illustrate how the application of the Act can be refined through such amendments. These Regulations commenced on the date of commencement of Part 3 of the Competition Policy Reform Act 1995.

Key Provisions

The Therapeutic Goods Regulations (Amendment) 1995 No. 328, issued under the authority of the Minister for Family Services, serves to modify the Therapeutic Goods Regulations in line with the Competition Policy Reform Act 1995. Section 63 of the Therapeutic Goods Act 1989 (the Act) empowers the Governor-General to establish regulations necessary for the Act's effective implementation. This amendment ensures that the name of the Trade Practices Commission is updated to reflect its replacement by the Australian Competition and Consumer Commission (ACCC), which will take over the responsibilities of the former entity. The Regulations, specifically Regulation 2, amend the definition of the "Therapeutic Goods Advertising Code." This Code, authorised by the Trade Practices Commission and adopted by the Media Council of Australia, aims to regulate and prohibit certain forms of advertising for therapeutic goods. Given the Trade Practices Commission’s abolition, the amendment updates the terminology to align with the new legislative framework, ensuring continuity and clarity in the enforcement of advertising standards for therapeutic goods. Entities subject to the Regulations must comply with the updated definition and the requirements of the Therapeutic Goods Advertising Code. This involves adhering to the advertising standards set forth by the ACCC to ensure that therapeutic goods are promoted in a manner that is truthful, not misleading, and does not unduly influence consumers. By aligning with the new authority, entities must ensure their advertising practices remain compliant with the updated regulatory environment. Breaches of the Therapeutic Goods Advertising Code can result in various consequences, including civil and criminal penalties. The precise nature and severity of these penalties depend on the specific breach and the discretion of the court. The ACCC has the authority to take enforcement actions, which may include fines, court orders, and other remedial measures to ensure compliance with the advertising standards for therapeutic goods. The maximum penalties can vary significantly depending on the nature and severity of the offence.